United States 119th Congress Status: In Committee Bipartisan · 26 D · 1 I cosponsors

S 1836 — SMART Prices Act

Last action — Read twice and referred to the Committee on Finance.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced May 21, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 42% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 27 sponsors

    1 primary, 26 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (26 D · 1 I) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

How this bill changes current law

9 changes Share ↗

Compared against current U.S. Code AI-generated reading aid — verify against the official bill.

The bill increases the number of negotiation-eligible drugs and modifies related definitions and price ceilings in the Drug Price Negotiation Program.

  • 42 U.S.C. 1320f-1(a)

    2028, 15 negotiation-eligible drugs → 2028 or a subsequent year, 50 negotiation-eligible drugs

    Increases the maximum number of drugs eligible for negotiation from 15 to 50 starting in 2028.

  • 42 U.S.C. 1320f-1(a)

    ; and → .

    Closes the list of drug negotiation criteria by removing a conjunction.

  • 42 U.S.C. 1320f-1(a)

    paragraph (4)

    Removes a section of the statute that likely detailed additional negotiation criteria for eligible drugs.

  • 42 U.S.C. 1320f-1(e)(1)

    7 years → 3 years

    Reduces the exclusive period for qualifying single source drugs from 7 years to 3 years.

  • 42 U.S.C. 1320f-1(e)(1)

    11 years → 3 years

    Reduces the window for additional qualifying criteria from 11 years to 3 years.

  • 42 U.S.C. 1320f-3(c)(3)

    75 percent → 76 percent

    Increases the ceiling for the maximum fair price from 75% to 76%.

  • 42 U.S.C. 1320f-3(c)(3)

    65 percent → 55 percent

    Decreases the second tier ceiling for the maximum fair price from 65% to 55%.

  • 42 U.S.C. 1320f-3(c)(3)

    40 percent → 30 percent

    Decreases the third tier ceiling for the maximum fair price from 40% to 30%.

  • The amendments made by this section shall apply with respect to initial price applicability years beginning with initial price applicability year 2028.

    Establishes that the new amendments will take effect starting with the price applicability year of 2028.

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Finance.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 26 co-sponsors · 520 not signed on

Sponsors (1)

Co-sponsors (26)

Not signed on (520)

520 members have not signed on to this bill.

Show all 520 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors S 1836?
S 1836 is sponsored by Welch, Peter (Democratic), Smith, Tina (Democratic), King, Angus S., Jr. (Independent), Cantwell, Maria (Democratic), Reed, Jack (Democratic), Whitehouse, Sheldon (Democratic), Duckworth, Tammy (Democratic), Warren, Elizabeth (Democratic), Gillibrand, Kirsten E. (Democratic), Merkley, Jeff (Democratic), Murray, Patty (Democratic), Blumenthal, Richard (Democratic), Shaheen, Jeanne (Democratic), Cortez Masto, Catherine (Democratic), Baldwin, Tammy (Democratic), Booker, Cory A. (Democratic), Van Hollen, Chris (Democratic), Durbin, Richard J. (Democratic), Murphy, Christopher (Democratic), Fetterman, John (Democratic), Markey, Edward J. (Democratic), Luján, Ben Ray (Democratic), Hassan, Margaret Wood (Democratic), Heinrich, Martin (Democratic), Slotkin, Elissa (Democratic), Bennet, Michael F. (Democratic), and Klobuchar, Amy (Democratic).
What is the current status of S 1836?
This bill is in committee in the Senate. Introduced May 21, 2025. It must pass committee before a floor vote.
Where can I track S 1836?
Track S 1836 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 1836

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 1836

Last checked for changes 4 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →